Clovis Oncology (NASDAQ:CLVS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Clovis Oncology missed estimated earnings by 2.33%, reporting an EPS of $-0.44 versus an estimate of $-0.43.
Revenue was down $3.81 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 20.99% increase in the share price the next day.
Here's a look at Clovis Oncology's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.56 | -0.48 | -0.56 | -0.72 |
| EPS Actual | -0.48 | -0.56 | -0.59 | -0.64 |
| Revenue Estimate | 39.08M | 39.09M | 41.12M | 44.55M |
| Revenue Actual | 35.97M | 37.92M | 36.82M | 38.05M |
To track all earnings releases for Clovis Oncology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
